Atlas Trials

A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)

Clinical trial NCT01868542 · COMPLETED

Trial details

NCT number
NCT01868542
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2013-06-01
Primary completion
2015-05-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.